Professor of Breast Surgery
Professor Alastair M Thompson, ALCM, BSc(Hons), MB ChB, MD, FRCSEd(Gen) has recently joined Baylor College of Medicine, Houston as Olga Keith Wiess Chair of Surgery and Co-Chair of the Dan L Duncan Breast Center. He was previously Professor of Surgical Oncology at the University of Dundee and from 2014 Professor of Surgery at the University of Texas, MD Anderson Cancer Center. He is co-author of more than 350 publications, continues to lead the Sloane Project and is co-principal investigator for the COMET trial for low-risk DCIS. He currently chairs the Translational Medicine Breast Group of SWOG; co-chairs the Loco-regional Steering Group of the Translational Breast Cancer Research Consortium (TBCRC), is a member of the NCI BOLD task force and of the Early Breast Cancer Trialists’ Collaborative Group.
Professor of Haematology
Dr Andrew Mumford is the Professor of Haematology at the University of Bristol and a Consultant in Haematology at University Hospitals Bristol. In these roles he leads a research group that focusses on the molecular genetics of rare haematological disorders.
Dr Mumford is also the Medical Director of the West of England Genomic Medicine Centre, one of thirteen National hub organisations responsible for delivery of the 100,000 Genomes Project and promoting uptake of Genomic Medicine into mainstream care. A major component of this effort has been the introduction of new sample collection pathways for solid tumours, analysis pipelines for whole genome tumour and germline results and dissemination of results to clinical MDT teams.
Data Protection Officer
Ardi Kolah LL.M is the Data Protection Officer (EMEA) for Hitachi Consulting and was responsible for directing Hitachi in being the first to achieve BS10012:2017 (Personal Information Management System) in the UK ahead of the GDPR. He’s currently working on a data protection project with Public Health England for the National Breast Cancer Screening Programme. Ardi is a Fellow of Henley Business School where he teaches on the GDPR Programme that has trained senior executives across a range of sectors, including healthcare. He’s worked closely with the Information Commissioner’s Office and was the judge for its inaugural DPO Awards 2017. He’s Editor-in-Chief of the Journal of Data Protection and Privacy and is a Committee Member on a security standard for the British Standards Institution (BSI) as well as being a chief examiner for the British Computer Society. A former senior manager at Andersen Consulting, Ardi holds a post-graduate in law from King’s College and University College London and writes and speaks extensively on data protection, privacy and security around the world.
Head of Legal Services
I am currently Head of Legal Services in Gloucestershire hospitals NHS Foundation trust and have held this position since 2002.
I am a Barrister, specialising in all aspects of healthcare law, with 20 years experience working within large NHS Trusts. My particular interests are inquests, managing disputes of all sorts, and teaching clinical staff about medico-legal issues.
I am also a Registered General Nurse having qualified at Charing Cross Hospital, and subsequently practised in Intensive Care and cardiac surgery in Guys Hospital and Bristol Royal Infirmary.
I continue to work on the wards when I can, as I place a high value on experiencing the working lives and conditions of my clinical colleagues. I hope that this keeps my advice to colleagues and approach to dispute management relevant and practical.
Professor of Medical Onocology
Professor Rea is a medical oncologist specialising in breast cancer research and treatment. He is the chief investigator for several large multicentre national and international clinical trials in early breast cancer – TEAM, aTTom, ROSCO, NOSTRA and Neoexel. He is a member of the trial management groups for the OPTIMA LORIS and AURORA trials.
He is the Chair of the NCRI Breast Clinical Studies Group supporting the development of the national breast clinical trials portfolio and leading on breast cancer research strategy for the NCRI. He is deputy director of the Cancer Research Clinical Trials Unit in Birmingham with responsibility for the late phase clinical trials programme. He is a member of the United Kingdom Breast Cancer Group (UKBCG) steering committee.
Professor Rea provides medical oncology services to the Breast Unit at University Hospital Birmingham where he runs a clinical trials focused practice. He has an active teaching role within the University, teaching and examining undergraduate and postgraduate courses.
Professor of Medical Physics
David has been Professor of Medical Physics at the University of Leeds since 2009 having previously worked at the University of Manchester (1999 – 2008) and the University of Florida (1996 – 1999). His research interests are in MRI and its use in measuring tissue and organ physiology, particularly through the application of tracer kinetic analysis to data acquired using dynamic contrast-enhanced MRI. David has used these approaches for over 20 years in several fields including oncology (e.g. breast, prostate, brain), renal medicine and cardiovascular imaging. His recent work brings him full circle having studied MRI of the breast for his PhD in the mid-1990s.
Eleanor Cornford joined the breast imaging team in Cheltenham in March 2017. Previously she spent 16 years in Nottingham. Her key interests are training and education with relevant roles including Director of Training and Education at the Nottingham Breast Unit until 2017, examiner for the FRCR 2b examination and Chair of Eusobi examination board until 2017
She spent 4 years as BSBR meetings secretary, finishing last year.
Research interests have focused on factors improving film reading performance.
Professor of Radiology
Professor Gilbert is Head of Department of Radiology at the University of Cambridge. Her role is to provide leadership to the diverse imaging community at the university and she is responsible for imaging research and radiological undergraduate teaching. Professor Gilbert’s clinical work and research is focused on all imaging techniques relating to breast cancer and oncology. She is interested in multimodal functional imaging with MRI and PET of the tumour environment using breast cancer as a model and correlating this with the tumour genetic profile. She undertakes research in stratified breast screening using Tomosynthesis, Whole Breast Ultrasound and contrast enhanced mammography. She maintains a strong interest in musculo-skeletal imaging.
Since 2012 Professor Gilbert has been awarded fifteen competitive grants worth over £20M. She is a member of the NIHR EME Board and is on a number of advisory panels.
Professor Gilbert has 197 peer reviewed publications, 5 book chapters and numerous conference abstracts. She is a regular speaker at international Radiology conferences in Chicago and Vienna as well as the European Society of Breast Imaging.
Julietta was responsible for overseeing the NHS Breast Screening Programme in England until she left Public Health England in August 2015. She had first joined the NHS in 1979 and been involved in screening since the establishment of the Breast Screening Programme in 1987. In 1990 she was appointed National Coordinator of the Breast Screening Programme and gradually took on increased responsibilities.
She was appointed Visiting Professor in Cancer Screening at the University of Oxford in April 2008 following increasing involvement in research there and an honorary fellowship. Her chief research interest is as PI of the breast screening Age Extension trial which randomises about 500,000 women per year.
Deputy Director of Cranfield Forensic Institute
Keith Rogers is Deputy Director of Cranfield Forensic Institute and has been developing techniques and approaches to characterise biological tissues using X-rays and spectroscopy for more than 35 years. Most of the activity has been focused upon the interpretation of elastic scattering signals and computer tomographic imaging.This has resulted in >160 publications that include an extensive range of applications; his work has been instrumental in the development of new biomaterials and the discovery of new biomarkers for osteoporosis and breast cancer.
His work is funded through a number of sources including the Research Councils, CRUK and the Department of Homeland Security.
Head of Scientific Computing
Mark is currently Head of Scientific Computing at Royal Surrey County Hospital. His teams remit covers involvement in a number of areas including Clinical Computing, Radiation Protection, Nuclear Medicine and Radiotherapy. The team are involved in the development of services and techniques for visualization, collection, analysis and investigation of medical imagery (including the development of the OPTIMAM Mammographic Image Database), improvement of QA services, development of Remote QC and dose monitoring capabilities. More recently, the team is involved with many cutting edge aspects of machine/deep-learning with medical images including radiogenomics..
Previous to this role, Mark was HSO in the computational biology group at the ICR working on development of a chemogenomic resources for capturing and integrating cancer drug discovery data. Prior to the ICR, he was a postdoc at Birkbeck College working in immunoinformatics as part of the FP6 project ImmunoGrid. This exciting project had him involved in the development of techniques for simulation of the immune system, large scale analysis of immune molecules and the application of computational techniques in vaccine design, development of tools and environments that enhance and utilise distributed computing and workflow and the use of molecular dynamic techniques to further T-cell epitope prediction.
Consultant Radiologist, Cambridge Breast Unit since November 2007.
Director of Screening July 2010 – Sept 2014
Before that Director Warwickshire, Solihull & Coventry Breast Screening Programme for 19 years.
Past President European Society of Breast Imaging 2010 – 2013
Clinical imaging lead (Breast) at the Cambridge Biomedical Research Centre and the Experimental Cancer Medicine Unit:
Monitoring and predicting breast tumour response in phase 1 and 2 trials.
Optimising existing and evaluating new imaging techniques and treatment for the breast and axilla.
His other research interest is anything and every thing affecting radiological and surgical performance in breast screening and using data to improve performance. In particular related to non operative diagnosis, staging of the breast and the diagnosis and management of DCIS.
Chief Investigator LORIS
104 peer review papers
Clinical Senior Lecturer in Surgical Onocology
Stuart McIntosh graduated from Edinburgh University in 1993 and undertook specialist surgical training in the North East of Scotland, with a National Oncoplastic Training Fellowship in Leeds, prior to taking up a post as a consultant breast surgeon in Aberdeen in 2005. Stuart moved to Belfast in 2009, and in 2015, reflecting his growing academic interest he took up an academic post as a Clinical Senior Lecturer in Surgical Oncology at Queen’s University Belfast. His research interests in the management of women at high risk of breast cancer, specifically BRCA1 mutation carriers, and in tailoring pre-surgical and surgical treatment for breast cancer to minimise surgical overtreatment.
Stuart is an experienced clinical trialist, and is the Royal College of Surgeons Surgical Specialty Lead for Breast Surgery, and a member of the NCRI Breast Clinical Studies Group. He is the Chief Investigator of the HTA-funded SMALL trial, a phase III randomised trial comparing conventional surgery with minimally assisted vacuum excision of small, good prognosis screen-detected breast cancers.
Director of Radiology
Dr. Maxine Jochelson is an attending radiologist on the Breast, Body and Molecular Imaging Services in the Department of Radiology at Memorial Sloan Kettering Cancer Center, a Professor of Radiology at MSK as well as an Associate Clinical Professor of Radiology at Cornell Weill Medical School. Her research at MSK focuses on advanced breast imaging techniques particularly for patients at increased risk of developing breast cancer, with the goal of providing accurate, cost effective imaging to improve cancer detection, provide direction for the most effective treatment options and of course to improve patient outcomes. Her primary specific research which directly addresses the above goals is the use of Contrast Enhanced Mammography (CEDM), a novel breast imaging method that uses intravenous contrast enhancement on a platform of digital mammography. While CEDM began as a diagnostic tool, she has led the movement toward its use in screening.
Another major interest is in the use of physiologic imaging to both diagnose, stage and follow patients with breast cancer. The use of FDG- PET/CT and other tracers is another focus of research interest. Dr Jochelson has worked closely with her clinical counterparts in medical oncology, breast surgery and radiation therapy throughout her career to both provide integrated patient care and multidisciplinary research.
Nico Karssemeijer is professor of Computer-Aided Diagnosis (CAD) in the Radiology department of the Radboud University Medical Centre Nijmegen, The Netherlands. In his scientific career he investigated the development and use of artificial intelligence in radiology, with a focus on breast cancer imaging. With his team he published over 150 peer reviewed papers on this topic. He has been serving on editorial boards of leading journals in the field, such as IEEE Transactions on Medical Imaging, Physics in Medicine and Biology and Medical Image Analysis. Nico Karssemeijer was closely involved in the development of the R2 ImageChecker, the first widely used CAD system in radiology. He is co-founder of Volpara (Wellington, New Zealand) and CEO of the deep learning company ScreenPoint Medical (Nijmegen, The Netherlands), which both develop advanced image analysis applications for breast imaging.
Dr Peter Bannister received his doctorate in Medical Image Analysis from the University of Oxford where he was one of the original developers of the FMRIB Software Library (FSL) which remains the gold standard for functional neuroimaging. He has held several senior executive positions in both start-up and publicly-listed, global medical device companies with responsibility for product development, R&D and international supply chain spanning technologies such as artificial intelligence for imaging biomarker development and laparoscopic surgery. Peter is a Chartered Engineer, Exec Chairman of the IET’s Healthcare Sector where he has a government policy and global standards remit, representing the Institution on matters related to Healthcare Technology and Biomedical Engineering in the national and international media.
Ruchi Sinnatamby has been delighted to have just completed the inaugural term of the RCR BSBR Travelling Professorship. She is a Consultant Radiologist from Cambridge whose major interests are in Breast Imaging and medical education. She performs screening and symptomatic breast imaging together with clinical research, in the Cambridge Breast Unit where she has run a very successful Breast Imaging Fellowship programme since 2000.
Ruchi very much enjoyed serving on the BSBR executive as the Society’s first Training Lead from 2009 to 2015. She has been an examiner for final FRCR since 2010, has just completed a 3 year term as a member of the RCR Specialty Training Board and continues to serve on the RCR Curriculum Committee.
She is also Clinical Sub-Dean for the Cambridge University School of Clinical Medicine and Vice President of Murray Edwards College, University of Cambridge.
More information coming soon...
More information coming soon...